• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICRO THERAPEUTICS, INC. DBA EV3 APOLLO; AGENT, INJECTABLE, EMBOLIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICRO THERAPEUTICS, INC. DBA EV3 APOLLO; AGENT, INJECTABLE, EMBOLIC Back to Search Results
Model Number UNK-NV-APOLLO
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Unspecified Infection (1930)
Event Date 09/13/2023
Event Type  Injury  
Manufacturer Narrative
G2: citation: authors: moosa, s.S., hasan, h., leyon, j.J., redha, n.A., <(>&<)> humaidan, h.Things are not what they seem neurologically and radiologically: an apt descriptor for spinal dural arteriovenous fistula (sdavf).Radiology case reports 18(11):4123-4129 2023.Doi:10.1016/j.Radcr.2023.08.082 earliest date of publication used for date of event no unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported.Without return of the product no definitive conclusion can be made regarding the clinical observations.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Moosa ss, hasan h, leyon jj, redha na, humaidan h.Things are not what they seem neurologically and radiologically: an apt descriptor for spinal dural arteriovenous fistula (sdavf).Radiology case reports.2023;18(11):4123-4129.Doi:10.1016/j.Radcr.2023.08.082 medtronic literature review found a report of patient complications in association with an apollo catheter.The purpose of this article was to present a case of spinal dural arteriovenous fistulas (sdavf) that was missed by the treating orthopedic surgeon and underwent spinal decompression with subsequent persistence of myelopathic symptoms.The patient was successful embolized with improved clinical outcomes for the patient using precipitating hydrophobic injectable liquid (phil) embolic agent delivered through an apollo catheter.The article does not state any technical issues during use of the apollo.The following intra- or post-procedural outcomes were noted:  - postembolization, the patient stayed in the hospital and underwent physical rehabilitation.The plan was to transfer the patient to a rehabilitation center.However, they didn¿t fulfill the requirements for transfer due to hospital-acquired infections and was discharged home where they had ongoing physiotherapy care.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
APOLLO
Type of Device
AGENT, INJECTABLE, EMBOLIC
Manufacturer (Section D)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer Contact
glen belmer
9775 toledo way
irvine, CA 92618
6122713209
MDR Report Key18717921
MDR Text Key335527296
Report Number2029214-2024-00297
Device Sequence Number1
Product Code MFE
Combination Product (y/n)N
Reporter Country CodeBA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 02/15/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/15/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberUNK-NV-APOLLO
Device Catalogue NumberUNK-NV-APOLLO
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/08/2024
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age61 YR
-
-